-
Figure 1 Types of medication-related problems in dialysis patients
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Manley HJ, et al. Medication prescribing patterns in ambulatory haemodialysis patients: Comparisons of USRDS to a large not-for-profit dialysis provider. Nephrol Dial Transplant 2004; 19: 1842–1848. doi: 10.1093/ndt/gfh280
-
2.
Manley HJ, Carroll CA. The clinical and economic impact of pharmaceutical care in end-stage renal disease patients. Semin Dial 2002; 15:45–49. doi: 10.1046/j.1525-139x.2002.00014.x
-
3.
Dyer SA, et al. Impact of medication reconciliation by a dialysis pharmacist. Kidney360, May 2022; 3:922–925. https://doi.org/10.34067/KID.0007182021
-
4.
Al Raiisi F, et al. Clinical pharmacy practice in the care of chronic kidney disease patients: A systematic review. Int J Clin Pharm 2019; 41:630–666. doi: 10.1007/s11096-019-00816-4
-
5.
Awdishu L, et al. A primer on quality assurance and performance improvement for interprofessional chronic kidney disease care: A path to Joint Commission certification. Pharmacy (Basel) 2019; 7:E83. doi: 10.3390/pharmacy7030083
The Role of Pharmacists in CKD Care Teams
Summer Dyer
Summer Dyer
Summer Dyer, PharmD, BCPS, is a dialysis pharmacist with the University of California San Diego (UCSD) Health system. She has developed the role of a dialysis pharmacist and implemented new clinical pharmacist services for chronic hemodialysis, including medication reconciliation, medication therapy management, guidelines for medication use, cost-containment strategies, and an innovative med-to-chair program in chronic hemodialysis. Linda Awdishu, PharmD, MAS, FASN, is Division Head and Professor of Clinical Pharmacy at the UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences. She practices at UCSD Health as a pharmacist specialist in kidney diseases and transplantation. Throughout her 20-plus-year career she has developed new, innovative clinical pharmacy practice models, such as interprofessional care in chronic kidney disease, safe drug distribution systems, medication reconciliation, and an innovative med-to-chair program in chronic hemodialysis, as well as discharge education and long-term follow-up clinics in kidney transplantation. She is a nephrology board member for the American Board of Internal Medicine and a member of the ASN Publications Committee.
Search for other papers by Summer Dyer in
Current site
Google Scholar
PubMed
Search for other papers by Summer Dyer in
Current site
Google Scholar
PubMed
Linda Awdishu
Linda Awdishu
Summer Dyer, PharmD, BCPS, is a dialysis pharmacist with the University of California San Diego (UCSD) Health system. She has developed the role of a dialysis pharmacist and implemented new clinical pharmacist services for chronic hemodialysis, including medication reconciliation, medication therapy management, guidelines for medication use, cost-containment strategies, and an innovative med-to-chair program in chronic hemodialysis. Linda Awdishu, PharmD, MAS, FASN, is Division Head and Professor of Clinical Pharmacy at the UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences. She practices at UCSD Health as a pharmacist specialist in kidney diseases and transplantation. Throughout her 20-plus-year career she has developed new, innovative clinical pharmacy practice models, such as interprofessional care in chronic kidney disease, safe drug distribution systems, medication reconciliation, and an innovative med-to-chair program in chronic hemodialysis, as well as discharge education and long-term follow-up clinics in kidney transplantation. She is a nephrology board member for the American Board of Internal Medicine and a member of the ASN Publications Committee.
Search for other papers by Linda Awdishu in
Current site
Google Scholar
PubMed
Search for other papers by Linda Awdishu in
Current site
Google Scholar
PubMed
© 2021 American Society of Nephrology | All Rights Reserved
Powered by: PubFactory
Powered by PubFactory